FY25 Full Year Results & FY26 Guidance Investor Presentation
Filed with ASX · · 26 pages · English
Summary by 6ix AI
The presentation highlights significant revenue growth and a transformation into three profit-generating business segments. Key highlights include a notable increase in cash flow from operations and a strong cash position at year-end.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Resonance Health
- TrialsWest Expands with New Clinical Trial Site
- Half Yearly Report and Accounts
- Non-deal Investor Roadshow Presentation
- Resonance Contracted by Major Global Pharma
- Trading Halt
Later from Resonance Health
- Investor Strategy Day Presentation
- AGM Presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Half Year Report & Accounts
- Half Year Results
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health